טוען...

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Early results of the fludarabine, cyclophosphamide, and rituximab (FCR) regimen in 224 patients showed that it was highly active as initial therapy of chronic lymphocytic leukemia. In this report, we present the final results of all 300 study patients at a median follow up of 6 years. The overall re...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Tam, Constantine S., O'Brien, Susan, Wierda, William, Kantarjian, Hagop, Wen, Sijin, Do, Kim-Anh, Thomas, Deborah A., Cortes, Jorge, Lerner, Susan, Keating, Michael J.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2008
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952498/
https://ncbi.nlm.nih.gov/pubmed/18411418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140582
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!